secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK:        0001062822
Form:       8-K
Filed at:   2021-08-02T23:59:59+00:00
Accession:  0001062822-21-000046
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexicon Pharmaceuticals announces principal accounting officer retirement and CMO appointment
--------------------------------------------------------------------------------

- James F. Tessmer to retire as VP of finance and accounting (principal accounting officer) effective Sept 24, 2021.
- Kristen L. Alexander, current controller, to succeed Tessmer as VP of finance and accounting and principal accounting officer on Sept 24, 2021.
- Craig B. Granowitz, M.D., Ph.D., appointed Senior VP and Chief Medical Officer effective Aug 2, 2021; previously CMO of Amarin.
- Dr. Granowitz brings prior experience from Merck & Co., Inc. and Schering-Plough Corporation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1062822/000106282221000046/0001062822-21-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1062822/000106282221000046/lxrx-20210728.htm
  HTML page:      https://secwatch.observer/filing/0001062822-21-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer